145 related articles for article (PubMed ID: 37395022)
41. The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer.
Tian WJ; Liu SS; Li BR
Technol Cancer Res Treat; 2020; 19():1533033820977504. PubMed ID: 33256552
[TBL] [Abstract][Full Text] [Related]
42. Advanced Glycation End Products' Receptor DNA Methylation Associated with Immune Infiltration and Prognosis of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Yang J; Lin M; Zhang M; Wang Z; Lin H; Yu Y; Zheng Q; Chen X; Wu Y; Yao Q; Li J
Genet Res (Camb); 2023; 2023():7129325. PubMed ID: 37497166
[TBL] [Abstract][Full Text] [Related]
43. Comprehensive Profiling of Genomic and Transcriptomic Differences between Risk Groups of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Zengin T; Önal-Süzek T
J Pers Med; 2021 Feb; 11(2):. PubMed ID: 33672117
[TBL] [Abstract][Full Text] [Related]
44. Smoking is Associated with Lung Adenocarcinoma and Lung Squamous Cell Carcinoma Progression through Inducing Distinguishing lncRNA Alterations in Different Genders.
Liu B; Liu Y; Zou J; Zou M; Cheng Z
Anticancer Agents Med Chem; 2022; 22(8):1541-1550. PubMed ID: 34315392
[TBL] [Abstract][Full Text] [Related]
45. Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
Liu X; Chen L; Zhang T
Cancer Control; 2018; 25(1):1073274818778001. PubMed ID: 29843532
[TBL] [Abstract][Full Text] [Related]
46. Network module function enrichment analysis of lung squamous cell carcinoma and lung adenocarcinoma.
Li P; Yuan H; Kuang X; Zhang T; Ma L
Medicine (Baltimore); 2022 Nov; 101(47):e31798. PubMed ID: 36451444
[TBL] [Abstract][Full Text] [Related]
47. LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma.
Liu B; Chen Y; Yang J
Oncotarget; 2017 Apr; 8(15):24275-24291. PubMed ID: 27903974
[TBL] [Abstract][Full Text] [Related]
48. Integrative metabolomics and transcriptomics analysis reveals novel therapeutic vulnerabilities in lung cancer.
Thaiparambil J; Dong J; Grimm SL; Perera D; Ambati CSR; Putluri V; Robertson MJ; Patel TD; Mistretta B; Gunaratne PH; Kim MP; Yustein JT; Putluri N; Coarfa C; El-Zein R
Cancer Med; 2023 Jan; 12(1):584-596. PubMed ID: 35676822
[TBL] [Abstract][Full Text] [Related]
49. The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC.
Fu L; Wang H; Wei D; Wang B; Zhang C; Zhu T; Ma Z; Li Z; Wu Y; Yu G
PLoS One; 2020; 15(5):e0233283. PubMed ID: 32437446
[TBL] [Abstract][Full Text] [Related]
50. Identifying prognostic biomarkers of non-small cell lung cancer by transcriptome analysis.
Xiong Y; Feng Y; Qiao T; Han Y
Cancer Biomark; 2020; 27(2):243-250. PubMed ID: 32083573
[TBL] [Abstract][Full Text] [Related]
51. Transcriptomic FHIT
Brisebarre A; Ancel J; Ponchel T; Loeffler E; Germain A; Dalstein V; Dormoy V; Durlach A; Delepine G; Deslée G; Polette M; Nawrocki-Raby B
Front Immunol; 2022; 13():1058531. PubMed ID: 36544755
[TBL] [Abstract][Full Text] [Related]
52. Nuclear TAZ activity distinctly associates with subtypes of non-small cell lung cancer.
Wang Y; Han Y; Guo Z; Yang Y; Ren T
Biochem Biophys Res Commun; 2019 Feb; 509(3):828-832. PubMed ID: 30638934
[TBL] [Abstract][Full Text] [Related]
53. Comparison of the somatic genomic landscape between central- and peripheral-type non-small cell lung cancer.
Wang L; Diao M; Zhang Z; Jiang M; Chen S; Zhao D; Liu Z; Zhou C
Lung Cancer; 2024 Jan; 187():107439. PubMed ID: 38113653
[TBL] [Abstract][Full Text] [Related]
54. The Effect of GLUT1 on the Survival Rate and Immune Cell Infiltration of Lung Adenocarcinoma and Squamous Cell Carcinoma: A Meta and Bioinformatics Analysis.
Zhang G; Dong R; Kong D; Liu B; Zha Y; Luo M
Anticancer Agents Med Chem; 2022; 22(2):223-238. PubMed ID: 34238200
[TBL] [Abstract][Full Text] [Related]
55. Epigenetic-smoking interaction reveals histologically heterogeneous effects of TRIM27 DNA methylation on overall survival among early-stage NSCLC patients.
Ji X; Lin L; Shen S; Dong X; Chen C; Li Y; Zhu Y; Huang H; Chen J; Chen X; Wei L; He J; Duan W; Su L; Jiang Y; Fan J; Guan J; You D; Shafer A; Bjaanaes MM; Karlsson A; Planck M; Staaf J; Helland Å; Esteller M; Wei Y; Zhang R; Chen F; Christiani DC
Mol Oncol; 2020 Nov; 14(11):2759-2774. PubMed ID: 33448640
[TBL] [Abstract][Full Text] [Related]
56. Lung adenocarcinoma and lung squamous cell carcinoma cancer classification, biomarker identification, and gene expression analysis using overlapping feature selection methods.
Chen JW; Dhahbi J
Sci Rep; 2021 Jun; 11(1):13323. PubMed ID: 34172784
[TBL] [Abstract][Full Text] [Related]
57. Prognostic value of immune-related genes in the tumor microenvironment of lung adenocarcinoma and lung squamous cell carcinoma.
Qu Y; Cheng B; Shao N; Jia Y; Song Q; Tan B; Wang J
Aging (Albany NY); 2020 Mar; 12(6):4757-4777. PubMed ID: 32209727
[TBL] [Abstract][Full Text] [Related]
58. Use of four genes in exosomes as biomarkers for the identification of lung adenocarcinoma and lung squamous cell carcinoma.
Cao B; Wang P; Gu L; Liu J
Oncol Lett; 2021 Apr; 21(4):249. PubMed ID: 33664813
[TBL] [Abstract][Full Text] [Related]
59. MiRNA expression profiling in adenocarcinoma and squamous cell lung carcinoma reveals both common and specific deregulated microRNAs.
Petkova V; Marinova D; Kyurkchiyan S; Stancheva G; Mekov E; Kachakova-Yordanova D; Slavova Y; Kostadinov D; Mitev V; Kaneva R
Medicine (Baltimore); 2022 Aug; 101(33):e30027. PubMed ID: 35984198
[TBL] [Abstract][Full Text] [Related]
60. Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelial-mesenchymal transition signature and longer survival in squamous cell lung carcinoma.
Jiang L; Zhu W; Streicher K; Morehouse C; Brohawn P; Ge X; Dong Z; Yin X; Zhu G; Gu Y; Ranade K; Higgs BW; Yao Y; Huang J
BMC Cancer; 2014 Feb; 14():131. PubMed ID: 24571613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]